Related Experiment Video
Updated: Jul 1, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Helicobacter pylori and non-malignant diseases
Haim Shirin1, Marcis Leja, Yaron Niv
1Gastroenterology Department, Rabin Medical Center, Tel Aviv University, Tel Aviv, Israel.
Helicobacter
|September 12, 2008
Summary
Helicobacter pylori research in 2007 addressed ongoing controversies regarding its role in peptic ulcer disease and dyspepsia. Despite declining ulcer rates, H. pylori remains a key factor in ulcer mortality, with ongoing research into its pathogenesis.
Area of Science:
- Gastroenterology
- Microbiology
- Infectious Diseases
Background:
- Helicobacter pylori research in 2007 continued to address persistent controversies from the previous decade.
- Key unresolved issues include peptic ulcer disease cases negative for H. pylori, the interaction between H. pylori and anti-inflammatory drugs, and the bacterium's role in dyspepsia.
- The potential protective effect of H. pylori against gastroesophageal reflux disease and associated cancers like Barrett's esophagus remained under investigation.
Purpose of the Study:
- To review and summarize the state of Helicobacter pylori research in 2007, focusing on controversial and unresolved issues.
- To highlight progress in understanding H. pylori's immunological processes and pathogenesis in specific patient groups.
- To underscore the continuing importance of H. pylori in ulcer-related mortality despite declining global incidence.
Main Methods:
- Literature review and synthesis of research published up to 2007.
- Analysis of trends in peptic ulcer disease incidence, prevalence, and mortality.
- Examination of studies investigating H. pylori's role in various gastrointestinal conditions and patient populations.
Main Results:
- The incidence and prevalence of peptic ulcer disease and associated mortality continued to decline globally.
- H. pylori was identified as the primary factor in ulcer-related mortality, irrespective of increased anti-inflammatory and antisecretory drug use.
- Progress was made in understanding H. pylori's immunological mechanisms, virulence factors, and pathogenesis in uremic and cirrhotic patients.
Conclusions:
- Despite declining ulcer rates, Helicobacter pylori remains a significant factor in gastrointestinal pathology and mortality.
- Further research is essential to fully elucidate the complex interactions between H. pylori, host factors, and disease outcomes.
- Unresolved questions regarding H. pylori's role in specific conditions necessitate continued investigation.
Related Concept Videos
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:30Peptic Ulcer Disease I: Introduction
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
01:25Peptic Ulcer Disease I: Introduction
Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.